ID   HS_ANXA1     standard; multiple; VRT.
XX
AC   EP73533;
XX
DT   06-JAN-2003 (Rel. 73, created)
DT   13-SEP-2004 (Rel. 80, Last annotation update).
XX
DE   Annexin A1.
OS   Homo sapiens (human).
XX
HG   none.
AP   none.
NP   none.
XX
DR   GENOME; NT_023935.17; NT_023935; [-4931312, 16576636].
DR   CLEANEX; HS_ANXA1.
DR   EMBL; AL359997.8; [-148061, 21041].
DR   EMBL; U25414.1; [-999, 266].
DR   SWISS-PROT; P04083; ANXA1_HUMAN.
DR   RefSeq; NM_000700.
DR   MIM; 151690.
XX
RN   [1]
RX   MEDLINE; 11752328.
RA   Suzuki Y., Yamashita R., Nakai K., Sugano S.;
RT   "DBTSS: database of human transcriptional start sites and
RT   full-length cDNAs";
RL   Nucleic Acids Res. 30:328-331(2002).
XX
ME   NEDO full length human cDNA sequencing project.
ME   Oligo-capping [1].
XX
SE   tggcttcctttaaaatcctataaaatcagaagcccaagtctccactgccAGTGTGAAATC
XX
FL             DBTSS     MGC
IF   -42  C    1         none
IF   -38  A    1
IF   -8   C    2
IF   -6   A    1
IF   -2   C    1
IF   -1   C    5
IF    0   A    27
IF   +1   G    3
IF   +4   T    1
IF   +11  T    1
IF   +29  T    1
XX
TX   6. Vertebrate promoters
TX   6.1. Chromosomal genes
TX   6.1.7. Unclassified
XX
KW   Annexin, Calcium/phospholipid-binding, Repeat, 3D-structure,
KW   Phospholipase A2 inhibitor, Phosphorylation, Acetylation.
XX
FP   Hs ANXA1            :+M  EU:NC_000009.10      1+  74956601; 73533.
XX
DO        Experimental evidence: 11
DO        Expression/Regulation:
RF        NAR30:328
//